Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Long-Time HELP Democrat Sen. Barbara Mikulski Plans To Retire By 2017

This article was originally published in The Gray Sheet

Executive Summary

Maryland Sen. Barbara Mikulski (D), the body’s longest-serving female Senator, former Appropriations Committee Chair and advocate of quality and comparative effectiveness provisions in the Affordable Care Act, recently announced her plans not to seek re-election in 2016 and retire.

You may also be interested in...



Reimbursement Briefs: CMS Delivery Reform Results; Hospital Differences Assessed; PCORI Updates

CMS releases results for health care delivery system reform initiatives. Health Affairs study explores differences between high- and low-price hospitals. PCORI adds more high-impact topics to pragmatic studies initiative and approves $5 million to fund methods research.

NIH, BRAIN Research Gets Boost In 2014 Senate Labor/HHS Bill

An appropriations bill passed by a Senate committee would increase the National Institutes of Health’s funding by $307 million to $31 billion in fiscal year 2014, including $40 million for President Obama’s BRAIN neurotechnology research initiative. Senate Appropriations Committee Chair Barbara Mikulski says she is determined to bring the Labor/HHS funding bill to the floor for debate.

Device Tax Delay? 18 Senate Dems Say ‘Yes’; Obama Says ‘No’

Potential delay of the device tax seemed to gain momentum with a recent letter from 18 Senate Democrats to Senate Majority Leader Reid, but the president and Senate Finance Committee leadership are not on board.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT033724

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel